Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 11 October, 2019

BlackRock Group

Form 8.3 - AbbVie Inc.

RNS Number : 6644P
BlackRock Group
11 October 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

AbbVie Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.01 common stock

Date of dealing

10 October 2019

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

(1) Relevant securities

83,699,592 (5.66%)

136,218 (0.00%)

(2) Derivatives (other than options)

823,433 (0.05%)

3,147,107 (0.21%)

(3) Options and agreements to purchase/sell

0 (0.00%)

82,400 (0.00%)

Total

84,523,025 (5.71%)

3,365,725 (0.22%)

             

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

270

USD 74.1691

Purchase

3,278

USD 74.4500

Purchase

975

USD 74.2714

Sale

4,649

USD 74.2746

Sale

9,990

USD 74.3291

   

Please note: there was also a Transfer In of 50,172 Shares

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Increasing Long

2,117

USD 74.3586

CFD

Increasing Long

463

USD 74.4039

CFD

Reducing Long

501

USD 74.1905

CFD

Increasing Short

17,349

USD 74.1600

   

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Call Option

Purchased

16,000

USD

71.5000

American

11/10/2019

USD

2.2700

Call Option

Purchased

32,000

USD

70.0000

American

18/10/2019

USD

3.7700

Call Option

Written

24,000

USD

75.0000

American

15/11/2019

USD

1.4400

Call Option

Written

24,000

USD

75.0000

American

22/11/2019

USD

1.6400

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Stock on Loan

1,940,892

USD 73.3000

Return of Stock on Loan

1,639,460

USD 73.3000

   

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                    YES

 

Date of disclosure

11 October 2019

Contact name

Jana Blumenstein

Telephone number

+44 20 7743 3650

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

18,400

USD

73.5000

American

25/10/2019

Call Option

Written

16,000

USD

72.0000

American

01/11/2019

Call Option

Written

24,000

USD

75.0000

American

15/11/2019

Call Option

Written

24,000

USD

75.0000

American

22/11/2019

 

Notes

 

1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 

          Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEGGGMWUUPBGPG

a d v e r t i s e m e n t